Fund HoldingsTAKEDA PHARMACEUTICAL CO LTD

Total Portfolio Value
$37.95M
Total Bought
$0
Total Sold
$114.83M
Net Transaction
-$114.83M
Filing Period:
Securities
SharesValue ($K)
Q2 2024
Q3 2024
Change
Q2 2024
Q3 2024
Weight (%)
Change
Wave Life Sciences Ltd.(WVE)1,346,8921,346,89206,72111,04529.10%+4,324
Ovid Therapeutics Inc.7,531,9967,531,99605,7928,88823.42%+3,095
Equillium, Inc.1,824,9771,824,97701,2591,5153.99%+255
American Well Corp1,554,66977,733-1,476,9365057371.94%+232
STANDARD BIOTOOLS INC.16,51516,515029320.08%+3
Shattuck Labs, Inc.515,619515,61901,9901,8004.74%-191
Xilio Therapeutics, Inc.1,475,1211,475,12101,3981,1623.06%-236
Akili, Inc.738,8190-738,8193210-321
Rani Therapeutics Holdings, Inc.215,172203,190-11,9828184391.16%-379
Turnstone Biologics Corp.895,824895,82402,3474991.31%-1,848
Phathom Pharmaceuticals, Inc.1,557,0630-1,557,06316,0380-16,038
HilleVax, Inc.6,724,0006,724,000097,22911,83531.18%-85,395
Denali Therapeutics Inc.(DNLI)4,214,5590-4,214,55997,8620-97,862
Page 1 of 1